Product Images Carvedilol
View Photos of Packaging, Labels & Appearance
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 12.5 mg - Carvedilol 12.5mg Aurobindo
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg - Carvedilol 25mg Aurobindo
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3.125 mg - Carvedilol 3.125mg Aurobindo
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 6.25 mg - Carvedilol 6.25mg Aurobindo
- Figure 1. Survival Analysis for CAPRICORN (intent-to-treat) - carvedilol fig1
- Figure 2. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig2
- Carvedilol Structure - carvedilol str
Product Label Images
The following 7 images provide visual information about the product associated with Carvedilol NDC 53808-0820 by State Of Florida Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 12.5 mg - Carvedilol 12.5mg Aurobindo
The text is describing a medication called "Carvedilol Tablets" with a dosage strength of 125M0. The label also includes a prescription requirement, indicated by "RxOnly". The UPC code is provided for inventory and tracking purposes.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg - Carvedilol 25mg Aurobindo
CARVEDILG is a prescription medication that comes in 25mg tablets. It is used to treat high blood pressure related to congestive heart failure and left ventricular dysfunction. This medication is controlled and requires a doctor's prescription. The manufacturer, dosage instructions, and other important information are not available in the given text.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3.125 mg - Carvedilol 3.125mg Aurobindo
Carvedilol is a medication in tablet form with a strength of 3.125 mg. The location listed is Talahassee, FL with a zip code of 32304. The remaining text contains an unclear reference and is not available.*
Figure 1. Survival Analysis for CAPRICORN (intent-to-treat) - carvedilol fig1
This is a graph displaying mortality rates for a treatment with Carvedilol compared to a placebo. The percent of mortality ranges from 0% to 30%, with a significant decrease in mortality observed in the Carvedilol group as indicated by the "P=003" label.*
Figure 2. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig2
This text appears to be a mixture of medical and statistical data, but it is not very readable due to errors and incomplete phrases. It is not possible to provide a useful description based on this text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.